How AI Is Transforming Pharmaceutical Research Workflows
- Scientific output is overwhelming researchers: 3.3 million science and engineering articles were published in 2022, up 59% in a decade, and teams often juggle 8–12 separate systems.
- McKinsey estimates AI could unlock up to $1 trillion in value for healthcare operations by automating labor-intensive research tasks.
- AI accelerates literature discovery, streamlines data management, and improves compliance and citation accuracy across pharmaceutical workflows.
- Tools like ReadCube centralize reference libraries, support AI-assisted review, automate content alerts, and strengthen regulatory documentation.
- AI is designed to supplement — not replace — scientific expertise, keeping human oversight and transparency at the center.
Submitted by Digital Science.
Originally published in Life Sciences Insights Magazine, August 2025
The pharmaceutical industry operates at the frontiers of science and medicine, but it faces daunting challenges as the pace of knowledge creation accelerates. With millions of scientific articles published annually and regulatory demands only growing, researchers and organizations are feeling the strain. Artificial intelligence (AI) is increasingly shaping workflows, helping companies streamline operations and enhance the pace of scientific breakthroughs.
This summary explores key challenges in pharmaceutical research, ways AI-powered solutions such as AI-driven solutions can address these issues, and the practical benefits that AI-powered tools can provide.
The Complexity of Pharmaceutical Research Workflows
Pharmaceutical companies rely on meticulous research and evidence-based decision-making, but the complexities of working with vast and fragmented data lead to significant obstacles.
Core Challenges
Information Overload: The volume of scientific literature is astonishing. In 2022, there were 3.3 million articles published globally in science and engineering, a 59% increase from a decade earlier. Staying updated on relevant studies amidst this flood of data overwhelms researchers and consumes valuable time.
Disjointed Systems: Traditional literature management involves scattered workflows across multiple platforms, causing inefficiencies, poor collaboration, and frustration. Researchers often toggle between 8 to 12 separate systems just to gather, review, and cite materials.
Regulatory Pressure: With patient safety a priority, pharmaceutical companies must rigorously document and comply with regulatory standards across various jurisdictions. Failures in citation accuracy or reference management can lead to missed deadlines, penalties, or credibility issues.
Smaller biopharmaceutical firms struggle to meet deadlines with fewer resources, while larger companies can find themselves navigating bureaucratic inefficiencies. In both cases, there is a clear need for more effective workflows.
How AI Bridges the Gap
AI is becoming a critical tool for addressing these challenges. McKinsey & Company estimates AI advancements could unlock up to $1 trillion in potential value for healthcare operations. AI’s ability to automate labor-intensive processes, analyze large data sets, and manage documents at scale paves the way for significant improvements in pharmaceutical research.
Key Benefits of AI in Research
Accelerated Literature Discovery: AI solutions can scan and summarize vast amounts of scientific literature in moments, saving hours of manual effort. Tools using natural language processing (NLP) also help refine searches, ensuring researchers surface relevant studies they might otherwise miss.
Streamlined Data Management: Centralized platforms enabled by AI consolidate data and workflows, allowing researchers to organize, annotate, and share insights without switching between numerous applications. Dashboards simplify data visualization, so teams can focus on actionable insights rather than combing through dense reports.
Improved Compliance and Accuracy: AI supports regulatory compliance by automating citation generation and document tagging, helping to reduce errors and maintain information integrity. Sophisticated algorithms can also trace data provenance, ensuring the quality and ethical use of research sources.
Approaches to AI-Powered Literature Management
AI can be integrated thoughtfully into pharmaceutical research processes to tackle many of the most common literature workflow challenges. Tools like ReadCube, for example, offer AI-powered features that support literature management and enhance the efficiency of research workflows. These approaches provide researchers with resources to manage information more efficiently.
Selected Capabilities
Centralized Reference Library: Scientific literature can be brought into a single, searchable space, simplifying organization and retrieval. Integration with extensive databases helps facilitate access to a broader range of documents and insights.
AI-Supported Review: AI functionalities can assist in identifying patterns, summarizing findings, and connecting information across studies. Users can interact with documents to clarify complex concepts and gain a deeper understanding of the research landscape.
Automated Content Alerts: Literature monitoring and alerts help teams stay informed as new research emerges, supporting ongoing awareness in rapidly evolving fields.
Workflow Support: Tools for annotating documents, managing evidence protocols, and building consistency in regulatory documentation support teams as they align their research processes.
Building Transparency and Collaboration
By supporting human oversight, AI-driven approaches can enhance researchers’ decision-making while maintaining transparency in the use of AI. These systems are designed to supplement expertise, allowing users to extract greater value from their existing workflows without replacing the core knowledge brought by scientific teams.
Driving Progress With AI
Across the industry, artificial intelligence is accelerating progress in drug discovery, regulatory compliance, and day-to-day research operations. AI reduces time spent on routine or repetitive tasks and helps teams focus on high-impact work. Examples such as the rapid development of the Moderna COVID-19 vaccine highlight the transformative potential of AI in pharmaceutical research. By effectively incorporating AI tools into their operations, pharmaceutical companies can improve efficiency and adapt to an ever-growing body of scientific knowledge.
Get the latest thought leadership from California’s life sciences sector in the quarterly Life Sciences Insights magazine. Share your own news and insights with CLS Member Voice.
FAQ: AI in Pharmaceutical Research Workflows
The three core challenges are information overload, disjointed systems, and regulatory pressure. Researchers must keep up with millions of new articles a year — 3.3 million were published in science and engineering in 2022 — while often toggling between 8 to 12 separate systems and meeting strict documentation and citation requirements.
AI accelerates literature discovery by scanning and summarizing vast bodies of research in moments, streamlines data management through centralized platforms, and improves compliance by automating citation generation and document tagging. McKinsey estimates these capabilities could unlock up to $1 trillion in value for healthcare operations.
It is the use of AI tools — such as ReadCube — to centralize and search scientific literature, assist with review by identifying patterns and summarizing findings, automate alerts about new research, and support consistent regulatory documentation. The goal is to manage a large, fast-growing body of information more efficiently.
No. These systems are designed to supplement scientific expertise, not replace it. They support human oversight and maintain transparency in how AI is used, allowing researchers to extract more value from their existing workflows while keeping decision-making with the scientific team.
According to McKinsey & Company, AI advancements could unlock up to $1 trillion in potential value for healthcare operations. That value comes from automating labor-intensive processes, analyzing large data sets, and managing documents at scale across research and compliance workflows.